ARTL Artelo Biosciences Inc

$ARTL They have big results coming out this year for thier glaucoma drug. If its a hit this will jump again. Waiting for that.

$ARTL Don't forget about the lunchtime dip. Don't get suckered out of your shares & sell at a loss, especially when this will hit $40-$50

$ARTL averaging down, let's go up please! So many other tickers ripping, hope the shorts have covered and give us a break !

$ARTL hope that was the last of it. Added on the dip. Should probably not be averaging up lol but I think this can run to 15. I'l be honest JAGX was looking a lot stronger at this time yesterday. But that ticker was such a beast. So I don't think it's a fair comparison. That having been said it could easily run to 30 AH without the halts. I'm looking for 15 I think. Let's see how she runs from here.

$ARTL selected for its first BIO-Europe 2026 company presentation, showcasing clinical progress of its FABP5 inhibitor platform.

$ARTL Looking pretty undervalued and ready to take off from this levels. With a 547K float this should be on your top potential squeeze watch.

$ARTL only 550k shares...extremely undervalued. Looks like someone is trying to bring it down and buy all the shares...

$ARTL Uitgebodemd rond de 5 dollar, morgen of begin volgende week naar 10 of meer dollar.

$ARTL don’t listen to this troll this he/she jumps in and out stocks that go up for the day spaming just look at he/she old messages 🤦‍♂️

$ARTL I am not robbed but a little ticked here is our no halt chance to have a big green candle

$ARTL Microfloat swing candidate. Float 540k 👀 Recent high of $15.73 23 Sep. Oversold at these levels. 📢 3.65

$ARTL I'm out for at least a month or two. Will it moon, or be $1.67. don't care either way. I've been in this stock for 4 years through 4 reverse splits. The pop in june, and this one has me up overall. Time to leave the table, GLA

$ARTL ART27.13, a dual cannabinoid receptor (GPCR) agonist, is being developed as a once-a-day, orally administered, benzimidazole derivative, highly potent, peripherally restricted new chemical entity, targeting CB1and CB2 receptors (learn more about CB1/CB2), with the potential to improve body weight, appetite, muscle degeneration, and quality of life in cancer patients. Artelo has announced positive clinical results in Phase 1 and Phase 2 studies of ART27.13. Currently, there is no FDA approved treatment for cancer anorexia cachexia syndrome.

$ARTL came back to check on you Bulls. I am out of this play and I am paranoid about holding most things overnight. However I want to give you Bulls a little encouragement. Obviously no one knows what will happen here. Clearly I don't or I would have sold the bulk at $15. However, if you believe every stock has a rhythm and a pattern and a way it does things, I invite you to take a look at their last pump back in March. The pump happened over a few days. On March 26th there was a huge tank. The following day, March 27th, it quadrupled itself. Maybe these guys aren't as amateurish as they look? Maybe they tanked it, are grabbing more shares at the bottom to run it again like the last time? I'll look for reentry tmo (maybe) Anyway, good luck Bulls.

$ARTL for something which was $94 6 months ago to 5.85 🤷‍♂️🤷‍♂️ this should be atleast $15 or $20 minimum strange

$ARTL 7$ seems to be holding support and macd is trying to cross over to positive again

$ARTL if power hour has any effect it’s gonna be from the last 15 minutes until close there’s no longer a power hour just a power quarter hour

$ARTL barhb’s rectangle law shows this hitting low 10$ wi th in the next hour. I’m doubling down

$ARTL had to drop it back down to eight dollars where all the shorts got in, always gotta let their short buddies out of their positions

$ARTL SCNI 600k bio float on launch pad under $2! MANAGEMENT says news could be coming any day now!